Brought to you by:
-
WVS 2022: New evidence of radiation reduction benefit emerges
Surgical augmented intelligence in the form of 3D mapping during complex aortic procedures can decrease radiation exposure, fluoroscopy time and contrast use when combined with real-time fluoroscopic images, a new analysis has established The results were presented during the 2022 Western Vascular Society (WVS) annual meeting in Victoria, Canada (Sept. 17–20), by Rohini Patel, MD,…
-
EVS 2022: Weaving magic in academic vascular surgery at JVS
Past Journal of Vascular Surgery (JVS) group editor-in-chief Peter Gloviczki, MD, invoked his hobby of magic to help illustrate what it requires to take the reins of an illustrious peer-reviewed publication like JVS during the Eastern Vascular Society (EVS) annual meeting in Philadelphia (Sept. 29–Oct. 1). Role models and mentors, commitment, the pursuit of competence,…
-
MVSS 2022: Study finds no link between frailty score and surgical site infection
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review carried out by Andrew Edsall, MD, a general surgery resident in the Gundersen Health System in La Crosse, Wisconsin, and colleagues. The research team sought to assess an adapted version of…
-
EVS 2022: New study shows ‘encouraging increase in academic footprint of female-driven research’
How does vascular surgery compare to other specialties in the growth of gender diversity in published research? “Are we leaders in the field, or are we trailing?” Those were questions posed by Monica Majumdar, MD, a general surgery resident at Tufts Medical Center in Boston, during the Eastern Vascular Society (EVS) annual meeting in Philadelphia…
-
Conference watch: Submit research to VRIC, VAM
Submissions already are open for 2023 Vascular Research Initiatives Conference (VRIC), which will be May 10, 2023, in Boston. The conference includes abstract sessions, a translational panel, posters and the Alexander W. Clowes Distinguished Lecture. VRIC is held in the same location and in conjunction with as the American Heart Association’s “Vascular Discovery: From Genes…
-
SVS vascular leaders: Cohort four of Leadership Development Program selected
Twenty-nine people have been selected for development as future leaders of the profession and the Society for Vascular Surgery (SVS). They represent cohort four of the Leadership Development Program (LDP), a nine-month-long interactive course designed to help them reach their full potential as leaders and positively impact their workplaces, communities, the vascular surgery specialty and…
-
NESVS 2022 Presidential Address: ‘We can create a bold new future for vascular surgery: It’s go time’
“Collaborate, innovate, mentor, champion DEI [diversity, equity, and inclusion] and relish the opportunity to form deep connections with our amazing patients.” This was the key take-home message delivered by Andres Schanzer, MD, chief of vascular surgery at the UMass Memorial Medical Center in Worcester, Massachusetts, during his Presidential Address at the New England Society for…
-
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their entry into the study, co-principal investigator Matthew Menard, MD, told the 2022 New England Society for Vascular Surgery (NESVS) annual meeting in Newport, Rhode Island (Oct. 14–16). The investigators were looking…
-
Roundtable on varicose veins guidelines set for Dec. 6
A virtual, multidisciplinary and interactive roundtable discussion on varicose veins will be held Dec. 6. The free roundtable, set for 6 to 7:30 p.m. CST, will be based on the recently published joint clinical practice guidelines developed by the Society for Vascular Surgery (SVS), American Venous Forum (AVF) and the American Vein and Lymphatic Society.…
-
Diversifying clinical trials: ‘There needs to be some kind of cultural competency’
The COVID-19 pandemic exposed lingering mistrust in the U.S. healthcare system among patients from minority communities as physicians continue to confront the conundrum of healthcare disparities in terms of outcomes alongside a lack of diversity in clinical trials, a roundtable discussion at Vascular Interventional Advances (VIVA) 2022 in Las Vegas (Oct. 31–Nov. 3) heard. Vincent…